Detalhe da pesquisa
1.
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.
Blood
; 143(2): 178-182, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37963262
2.
A TIAM1-TRIM28 complex mediates epigenetic silencing of protocadherins to promote migration of lung cancer cells.
Proc Natl Acad Sci U S A
; 120(40): e2300489120, 2023 10 03.
Artigo
Inglês
| MEDLINE | ID: mdl-37748077
3.
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis.
Nature
; 574(7777): 273-277, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31578525
4.
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia.
Br J Haematol
; 201(2): 302-307, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36746431
5.
Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
BMC Cancer
; 21(1): 1153, 2021 Oct 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34711181
6.
Chronic myeloid leukemia presenting as compartment syndrome with acute loss of upper limb function.
Am J Emerg Med
; 49: 273-275, 2021 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34174777
7.
Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancer.
BMC Cancer
; 20(1): 1075, 2020 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33167906
8.
Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Am J Hematol
; 95(7): 824-833, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32279331
9.
EVI1 oncoprotein expression and CtBP1-association oscillate through the cell cycle.
Mol Biol Rep
; 47(10): 8293-8300, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32979164
10.
EVI1 carboxy-terminal phosphorylation is ATM-mediated and sustains transcriptional modulation and self-renewal via enhanced CtBP1 association.
Nucleic Acids Res
; 46(15): 7662-7674, 2018 09 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29939287
11.
The management of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 136-150, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38037886
12.
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
Br J Haematol
; 204(1): 127-135, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37932932
13.
Development of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1.
Bioorg Med Chem Lett
; 27(14): 3190-3195, 2017 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28545974
14.
Development and evaluation of 4-(pyrrolidin-3-yl)benzonitrile derivatives as inhibitors of lysine specific demethylase 1.
Bioorg Med Chem Lett
; 27(20): 4755-4759, 2017 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28927796
15.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.
Cancer Cell
; 10(4): 257-68, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17045204
16.
PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cells.
Cancer Cell
; 10(6): 456-7, 2006 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17157786
17.
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.
Nature
; 455(7217): 1205-9, 2008 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-18806775
18.
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial.
Leuk Lymphoma
; : 1-13, 2024 Mar 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38501751
19.
CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1.
Anal Biochem
; 442(1): 104-6, 2013 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23911524
20.
Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patients.
PLoS One
; 18(5): e0286412, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37253035